
No. of Pages: 92 | Report Code: BMIRE00029269 | Category: Life Sciences
No. of Pages: 92 | Report Code: BMIRE00029269 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Glioma Treatment Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Government Funding for Glioma Treatment
4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:
5. Middle East & Africa Glioma Treatment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
6.1 Overview
6.2 Middle East & Africa Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
6.3.1 Overview
6.3.2 Astrocytoma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
6.4.1 Overview
6.4.2 Oligoastrocytoma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
6.5.1 Overview
6.5.2 Oligodendroglioma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 Middle East & Africa Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
7.3.1 Overview
7.3.2 Surgery: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Chemotherapy: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
7.5.1 Overview
7.5.2 Radiation Therapy: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
8.1 Overview
8.2 Middle East & Africa Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
8.3.1 Overview
8.3.2 Low Grade: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Grade I: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Grade II: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
8.4.1 Overview
8.4.2 High Grade: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Grade III: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.2 Grade IV: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Middle East & Africa Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
9.3.1 Overview
9.3.2 Hospital & Clinics: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. Glioma Treatment Market - Middle East & Africa Analysis
10.1.1 Overview
10.1.2 Middle East & Africa Glioma Treatment Market, by Country
10.1.2.1 Saudi Arabia
10.1.2.1.1 Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.2 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by Disease
10.1.2.1.3 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by Treatment Type
10.1.2.1.4 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by Grade
10.1.2.1.4.1 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by Low Grade
10.1.2.1.4.2 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by High Grade
10.1.2.1.5 Saudi Arabia: Middle East & Africa Glioma Treatment Market, by End User
10.1.2.2 South Africa
10.1.2.2.1 South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.2 South Africa: Middle East & Africa Glioma Treatment Market, by Disease
10.1.2.2.3 South Africa: Middle East & Africa Glioma Treatment Market, by Treatment Type
10.1.2.2.4 South Africa: Middle East & Africa Glioma Treatment Market, by Grade
10.1.2.2.4.1 South Africa: Middle East & Africa Glioma Treatment Market, by Low Grade
10.1.2.2.4.2 South Africa: Middle East & Africa Glioma Treatment Market, by High Grade
10.1.2.2.5 South Africa: Middle East & Africa Glioma Treatment Market, by End User
10.1.2.3 UAE
10.1.2.3.1 UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.2 UAE: Middle East & Africa Glioma Treatment Market, by Disease
10.1.2.3.3 UAE: Middle East & Africa Glioma Treatment Market, by Treatment Type
10.1.2.3.4 UAE: Middle East & Africa Glioma Treatment Market, by Grade
10.1.2.3.4.1 UAE: Middle East & Africa Glioma Treatment Market, by Low Grade
10.1.2.3.4.2 UAE: Middle East & Africa Glioma Treatment Market, by High Grade
10.1.2.3.5 UAE: Middle East & Africa Glioma Treatment Market, by End User
10.1.2.4 Rest of Middle East & Africa
10.1.2.4.1 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.2 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by Disease
10.1.2.4.3 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by Treatment Type
10.1.2.4.4 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by Grade
10.1.2.4.4.1 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by Low Grade
10.1.2.4.4.2 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by High Grade
10.1.2.4.5 Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market, by End User
11. Glioma Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Amgen Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Amneal Pharmaceuticals Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Karyopharm Therapeutics Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Biocon Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Glioma Treatment Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
Table 6. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 13. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 25. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Organic Developments Done By Companies
Table 27. Inorganic Developments Done By Companies
Table 28. Glossary of Terms, glioma treatment market
List of Figures
Figure 1. Middle East & Africa Glioma Treatment Market Segmentation, By Country
Figure 2. Middle East & Africa Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Middle East & Africa Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Middle East & Africa Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Middle East & Africa Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Glioma Treatment Market, By Country, 2022 ($Mn)
Figure 25. Middle East & Africa Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. Saudi Arabia: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. UAE: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Middle East & Africa: Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies Done by the Companies in the Market, (%)
1. Amgen Inc
2. Amneal Pharmaceuticals Inc
3. Biocon Ltd
4. F. Hoffmann-La Roche Ltd
5. Karyopharm Therapeutics Inc
6. Merck & Co Inc
7. Pfizer Inc
8. Sun Pharmaceutical Industries Ltd
9. Teva Pharmaceutical Industries Ltd